Retrospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11326-11332
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11326
Figure 1
Figure 1 Mean model of end stage liver disease scores for study population per year. P value = 0.20 reflects trend for MELD scores for cirrhosis of all causes. P value = 0.27 reflects comparison of ALC and NALC groups. MELD: Model for end-stage liver disease; All: Cirrhosis all causes; ALC: Alcoholic cirrhosis; NALC: Non-alcoholic cirrhosis.
Figure 2
Figure 2 Admissions with cirrhosis per 100000 IP visits based on etiology of cirrhosis. P values are for trend. All: Cirrhosis all causes; ALC: Alcoholic cirrhosis; NALC: Non-alcoholic cirrhosis.
Figure 3
Figure 3 Trends in admissions for variceal bleeding per 100000 inpatient visits based on etiology of cirrhosis. A: Total variceal bleeds; B: Index variceal bleeds; C: Variceal rebleeding. P values are for trend during study period. All: Cirrhosis all causes; ALC: Alcoholic cirrhosis; NALC: Non-alcoholic cirrhosis.
Figure 4
Figure 4 Transjugular intrahepatic portosystemic shunt placement 1998-2009. P values are for trend. TIPS: Transjugular intrahepatic portosystemic shunt; GI: Gastrointestinal.
Figure 5
Figure 5 Hospital deaths per 100000 admissions based on etiology of cirrhosis. P value is for trend. All: Cirrhosis all causes; ALC: Alcoholic cirrhosis; NALC: Non-alcoholic cirrhosis.
Figure 6
Figure 6 Non-selective beta-blocker usage amongst patients with variceal index bleeding and recurrent variceal bleeding. NSBB: Nonselective beta-blocker. P values are for trend.